GeoVax Labs Statistics

Total Valuation

GeoVax Labs has a market cap or net worth of $3.18 million. The enterprise value is $968,182.

Market Cap	3.18M
Enterprise Value	968,182

Important Dates

The last earnings date was Wednesday, April 15, 2026.

Earnings Date	Apr 15, 2026
Ex-Dividend Date	n/a

Share Statistics

GeoVax Labs has 2.89 million shares outstanding. The number of shares has increased by 361.94% in one year.

Current Share Class	2.89M
Shares Outstanding	2.89M
Shares Change (YoY)	+361.94%
Shares Change (QoQ)	+113.74%
Owned by Insiders (%)	0.13%
Owned by Institutions (%)	9.49%
Float	2.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.29
Forward PS	n/a
PB Ratio	0.50
P/TBV Ratio	0.84
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.39
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.74, with a Debt / Equity ratio of 0.22.

Current Ratio	2.74
Quick Ratio	1.59
Debt / Equity	0.22
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -483.79% and return on invested capital (ROIC) is -278.37%.

Return on Equity (ROE)	-483.79%
Return on Assets (ROA)	-186.57%
Return on Invested Capital (ROIC)	-278.37%
Return on Capital Employed (ROCE)	-491.22%
Weighted Average Cost of Capital (WACC)	19.94%
Revenue Per Employee	$146,420
Profits Per Employee	-$1.26M
Employee Count	17
Asset Turnover	0.34
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -95.50% in the last 52 weeks. The beta is 3.80, so GeoVax Labs's price volatility has been higher than the market average.

Beta (5Y)	3.80
52-Week Price Change	-95.50%
50-Day Moving Average	1.45
200-Day Moving Average	9.39
Relative Strength Index (RSI)	32.03
Average Volume (20 Days)	95,815

Short Selling Information

The latest short interest is 277,558, so 9.60% of the outstanding shares have been sold short.

Short Interest	277,558
Short Previous Month	252,981
Short % of Shares Out	9.60%
Short % of Float	9.61%
Short Ratio (days to cover)	3.83

Income Statement

In the last 12 months, GeoVax Labs had revenue of $2.49 million and -$21.46 million in losses. Loss per share was -$22.40.

Revenue	2.49M
Gross Profit	-15.63M
Operating Income	-21.64M
Pretax Income	-21.46M
Net Income	-21.46M
EBITDA	-21.57M
EBIT	-21.64M
Loss Per Share	-$22.40

Full Income Statement

Balance Sheet

The company has $3.09 million in cash and $843,170 in debt, giving a net cash position of $2.24 million or $0.78 per share.

Cash & Cash Equivalents	3.09M
Total Debt	843,170
Net Cash	2.24M
Net Cash Per Share	$0.78
Equity (Book Value)	3.83M
Book Value Per Share	2.21
Working Capital	3.38M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$21.47 million and capital expenditures -$27,612, giving a free cash flow of -$21.50 million.

Operating Cash Flow	-21.47M
Capital Expenditures	-27,612
Depreciation & Amortization	68,756
Net Borrowing	n/a
Free Cash Flow	-21.50M
FCF Per Share	-$7.43

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-869.34%
Pretax Margin	-862.34%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GeoVax Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-361.94%
Shareholder Yield	-361.94%
Earnings Yield	-668.53%
FCF Yield	-669.67%

Analyst Forecast

The average price target for GeoVax Labs is $1.00, which is -9.09% lower than the current price. The consensus rating is "Hold".

Price Target	$1.00
Price Target Difference	-9.09%
Analyst Consensus	Hold
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 12, 2026. It was a reverse split with a ratio of 1:25.

Last Split Date	Jan 12, 2026
Split Type	Reverse
Split Ratio	1:25

Scores

GeoVax Labs has an Altman Z-Score of -39.79 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-39.79
Piotroski F-Score	1